Lung adenocarcinoma tissue microarray, containing 75 cases of lung adenocarcinoma, single core per case. Pathology grade, TNM Classification and Clinical Stages information available. Replacing LC706.
Price
$255.00
Catalogue No | RLN706a |
Description | Lung adenocarcinoma tissue microarray, containing 75 cases of lung adenocarcinoma, single core per case. Pathology grade, TNM Classification and Clinical Stages information available. Replacing LC706. |
Species | Human |
Fixative | Formalin |
Total Cases | 75 |
Total Cores | 75 |
Core Diameter | 1.5 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
B | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
C | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
D | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
E | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
F | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
G | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
H | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
I | LU | LU | LU | LU | LU | LU | LU | LU | ||||||||||||||||||||||||||||||||||||||||||||||||||
J | LU | LU | LU | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
N | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 54 | M | Lung | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant |
2 | A2 | 65 | F | Lung | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant |
3 | A3 | 61 | M | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
4 | A4 | 53 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
5 | A5 | 65 | M | Lung | Adenocarcinoma | 1 | T2N0MO | I | Malignant |
6 | A6 | 70 | F | Lung | Adenocarcinoma | 1 | T1N0M0 | IA | Malignant |
7 | A7 | 60 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
8 | A8 | 67 | F | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIA | Malignant |
9 | B1 | 69 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
10 | B2 | 56 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
11 | B3 | 65 | M | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIA | Malignant |
12 | B4 | 75 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
13 | B5 | 48 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
14 | B6 | 66 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
15 | B7 | 64 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
16 | B8 | 59 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
17 | C1 | 62 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
18 | C2 | 68 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
19 | C3 | 63 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
20 | C4 | 64 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IIA | Malignant |
21 | C5 | 37 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
22 | C6 | 59 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
23 | C7 | 59 | M | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
24 | C8 | 67 | M | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
25 | D1 | 68 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
26 | D2 | 72 | F | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
27 | D3 | 82 | M | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant |
28 | D4 | 71 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | I | Malignant |
29 | D5 | 42 | M | Lung | Adenocarcinoma | 3 | T1N0M0 | IB | Malignant |
30 | D6 | 52 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
31 | D7 | 75 | F | Lung | Adenocarcinoma | - | T2N1M0 | IIB | Malignant |
32 | D8 | 70 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
33 | E1 | 54 | F | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant |
34 | E2 | 47 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
35 | E3 | 38 | M | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant |
36 | E4 | 32 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
37 | E5 | 65 | F | Lung | Adenocarcinoma | 3 | T2N2M0 | IIIA | Malignant |
38 | E6 | 38 | M | Lung | Adenocarcinoma | 2 | T4N2M0 | IIIB | Malignant |
39 | E7 | 57 | M | Lung | Adenocarcinoma | 3 | T4N0M0 | IIIA | Malignant |
40 | E8 | 52 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
41 | F1 | 72 | M | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
42 | F2 | 39 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
43 | F3 | 61 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
44 | F4 | 59 | M | Lung | Adenocarcinoma | 2 | T4N3M0 | IIIB | Malignant |
45 | F5 | 59 | F | Lung | Adenocarcinoma | 2 | T2N1M0 | IIB | Malignant |
46 | F6 | 64 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
47 | F7 | 49 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
48 | F8 | 62 | M | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
49 | G1 | 58 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
50 | G2 | 58 | F | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant |
51 | G3 | 32 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
52 | G4 | 50 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
53 | G5 | 65 | M | Lung | Adenocarcinoma | 3 | T3N0M0 | IIB | Malignant |
54 | G6 | 39 | - | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
55 | G7 | 73 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
56 | G8 | 48 | M | Lung | Adenocarcinoma | 3 | T3N1M0 | IIIA | Malignant |
57 | H1 | 64 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
58 | H2 | 64 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
59 | H3 | 61 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
60 | H4 | 53 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIA | Malignant |
61 | H5 | 67 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
62 | H6 | 30 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
63 | H7 | 65 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
64 | H8 | 59 | F | Lung | Adenocarcinoma | 3 | T2N1M1 | IIA | Malignant |
65 | I1 | 58 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
66 | I2 | 51 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
67 | I3 | 69 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
68 | I4 | 60 | M | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
69 | I5 | 61 | F | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
70 | I6 | 49 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
71 | I7 | 72 | F | Lung | Adenocarcinoma | 3 | T2N1M0 | IIB | Malignant |
72 | I8 | 36 | F | Lung | Adenocarcinoma | 3 | T2N2M0 | IIIA | Malignant |
73 | J1 | 56 | F | Lung | Adenocarcinoma | 3 | T2AN1M0 | IIA | Malignant |
74 | J2 | 75 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
75 | J3 | 74 | M | Lung | Adenocarcinoma (sparse) | - | T2N0M0 | IB | Malignant |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |